Jens Bedke, Thomas Powles, Begoña P. Valderrama, Shilpa Gupta, Eiji Kikuchi, Yohann Loriot, Matthew D. Galsky, Srikala S. Sridhar, Evan Y. Yu, Jeannie Hoffman-Censits, Gopa Iyer, Daniel Castellano, Pablo Maroto-Rey, Nataliya Mar, Nancy Ann Dawson, Abhishek Bavle, Seema Rao Gorla, Xuesong Yu, Yi-Tsung Lu, Michiel Simon Van Der Heijden. "EV-302: Long-term subgroup analysis from the phase 3 global study of enfortumab vedotin in combination with pembrolizumab (EV+P) vs chemotherapy (chemo) in previously untreated locally advanced or metastatic urothelial carcinoma (la/mUC).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.4571